KETAMINE

CO-CHAIRS

Mark Niciu, MD, PhD | University of Iowa
Robert Meisner, MD | McLean Hospital

WHY A TASK GROUP?

In November 2019, the NNDC approved the creation of a working group on racemic ketamine and bioactive ketamine metabolites, including esketamine. The purpose of the NNDC Ketamine Interest Task Group is to address the emerging need to share information and learn from each other’s experiences as ketamine and esketamine clinics are established across the Network.


PAGE UNDER CONSTRUCTION!
We apologize for the inconvenience.

 

INTERESTED IN JOINING?

Researchers from our current member institutions should contact Program Manager, Diana Burnett, at dburnett@nndc.org for more information about being added to the task group.

Unfortunately, we are not accepting non-affiliated researchers at this time to our Task Groups. We encourage researchers who are not from our member institutions to talk to their current institution leadership about becoming a member of our network. More information about joining the NNDC can be found on our membership opportunities page: https://nndc.org/membership/